Clinical trialNCT02576561UnknownPhase 2Interventional

Safety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSIL

SponsorTHEVAX Genetics VaccineEnrollment10High-Grade Squamous Intraepithelial LesionsHuman Papillomavirus

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this research study is to test the safety and effectiveness of the investigational study vaccine, called TVGV-1. The study will test the vaccine in women with high grade HPV cervical infection.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Frank L Douglas, PhD, MD
THEVAX Genetics Vaccine
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Visions Clinical Research - Tucson
Tucson, Arizona, United States
Red Rocks Obgyn
Lakewood, Colorado, United States
Progressive Medical Research
Port Orange, Florida, United States
Comprehensive Clinical Trials, Llc
West Palm Beach, Florida, United States
Grady Memorial Hospital
Atlanta, Georgia, United States
Prohealth Care Associates Llp
Port Jefferson, New York, United States
Unified Women'S Clinical Research
Raleigh, North Carolina, United States
Unified Women'S Clinical Research
Winston-Salem, North Carolina, United States
Complete Healthcare for Women
Columbus, Ohio, United States
Penn Fertility Care/reproductive Research Unit Univ of Pennsylvania
Philadelphia, Pennsylvania, United States
Insearch-Tidewater Clinical Research
Norfolk, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

GPI-0100PlaceboTVGV-1

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Nov 2015
Primary completion: 31 May 2018
Completion: 30 Sept 2018
Last update posted: 25 Oct 2017
Registered enrollment: 10
Registry id: NCT02576561

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.